Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1994 2
1995 4
1996 2
1997 1
1999 1
2000 8
2001 3
2003 5
2004 6
2005 6
2006 6
2007 6
2008 8
2009 4
2010 7
2011 9
2012 23
2013 12
2014 10
2015 10
2016 9
2017 6
2018 3
2019 7
2020 2
2021 1
2022 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Results by year

Filters applied: . Clear all
Page 1
Uptake in cancer screening programmes.
Weller DP, Patnick J, McIntosh HM, Dietrich AJ. Weller DP, et al. Among authors: patnick j. Lancet Oncol. 2009 Jul;10(7):693-9. doi: 10.1016/S1470-2045(09)70145-7. Lancet Oncol. 2009. PMID: 19573798 Review.
Maximising benefit and minimising harm of screening.
Gray JA, Patnick J, Blanks RG. Gray JA, et al. Among authors: patnick j. BMJ. 2008 Mar 1;336(7642):480-3. doi: 10.1136/bmj.39470.643218.94. BMJ. 2008. PMID: 18310003 Free PMC article.
The dimensions of the CRC problem.
Karsa LV, Lignini TA, Patnick J, Lambert R, Sauvaget C. Karsa LV, et al. Among authors: patnick j. Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):381-96. doi: 10.1016/j.bpg.2010.06.004. Best Pract Res Clin Gastroenterol. 2010. PMID: 20833343
False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes.
Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, Giordano L, Frigerio A, Törnberg S; EUNICE Project and Euroscreen Working Groups; Van Hal G, Martens P, Májek O, Danes J, von Euler-Chelpin M, Aasmaa A, Anttila A, Becker N, Péntek Z, Budai A, Mádai S, Fitzpatrick P, Mooney T, Zappa M, Ventura L, Scharpantgen A, Hofvind S, Seroczynski P, Morais A, Rodrigues V, Bento MJ, Gomes de Carvalho J, Natal C, Prieto M, Sánchez-Contador Escudero C, Zubizarreta Alberti R, Fernández Llanes SB, Ascunce N, Ederra Sanza M, Sarriugarte Irigoien G, Salas Trejo D, Ibáñez Cabanell J, Wiege M, Ohlsson G, Törnberg S, Korzeniewska M, de Wolf C, Fracheboud J, Patnick J, Lancucki L, Ducarroz S, Suonio E. Hofvind S, et al. Among authors: patnick j. J Med Screen. 2012;19 Suppl 1:57-66. doi: 10.1258/jms.2012.012083. J Med Screen. 2012. PMID: 22972811 Review.
ABC of breast diseases: screening for breast cancer.
Blamey RW, Wilson AR, Patnick J. Blamey RW, et al. Among authors: patnick j. BMJ. 2000 Sep 16;321(7262):689-93. doi: 10.1136/bmj.321.7262.689. BMJ. 2000. PMID: 10987778 Free PMC article. Review. No abstract available.
Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.
Roddam AW, Duffy MJ, Hamdy FC, Ward AM, Patnick J, Price CP, Rimmer J, Sturgeon C, White P, Allen NE; NHS Prostate Cancer Risk Management Programme. Roddam AW, et al. Among authors: patnick j. Eur Urol. 2005 Sep;48(3):386-99; discussion 398-9. doi: 10.1016/j.eururo.2005.04.015. Eur Urol. 2005. PMID: 15982797 Review.
145 results